Accessibility Menu
 

The Sequoia Fund Finally Exits Valeant Pharmaceuticals: 2 Lessons for Investors From a Fiasco

The Sequoia Fund disclosed that it has sold its remaining stake in troubled drug company Valeant Pharmaceuticals, but there are valuable lessons for investors to learn from Sequoia's multibillion-dollar mistake.

By Alex Dumortier, CFA Jul 13, 2016 at 12:31PM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.